Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 13 September 2024
Accepted: 17 February 2025
First Online: 26 March 2025
Competing interests
: C.R.B. is a cofounder and scientific advisory board member of Lycia Therapeutics, Palleon Pharmaceuticals, Enable Biosciences, Redwood Bioscience (a subsidiary of Catalent), OliLux Bio, InterVenn Bio, Grace Science, Firefly Bio, Neuravid and Valora Therapeutics. C.R.B. is also on the board of directors of Alnylam, OmniAb and Xaira Therapeutics. N.A.T. and M.R. declare no competing interests.
